Prognostic utility of the global leadership initiative on malnutrition criteria in predicting outcomes after hepatectomy for hepatocellular carcinoma: a multicenter, retrospective study

全球营养不良领导倡议标准在预测肝细胞癌肝切除术后预后中的应用价值:一项多中心回顾性研究

阅读:2

Abstract

OBJECTIVE: The Global Leadership Initiative on Malnutrition (GLIM) criteria were developed to standardize diagnoses of malnutrition. However, the prognostic utility of the GLIM criteria and predictive models including GLIM criteria in patients diagnosed with hepatocellular carcinoma (HCC) undergoing hepatectomy remains largely unexplored. METHODS: This retrospective study included 477 HCC patients who underwent curative hepatectomy at two centers (training cohort: n = 297, January 2014 to November 2020; validation cohort: n = 180, April 2018 to December 2019). A nomogram was developed using multivariate Cox regression analysis. The utility of the developed model was evaluated by Harrell concordance index (C-index), calibration curve, and decision curve analysis (DCA). Time-dependent receiver operating characteristic (ROC) curves and DCA were used to compare the nomogram with existing prognostic models. RESULTS: The prevalence of malnutrition was 30.6 and 25.6% in the training and validation cohorts, respectively. Non-malnourished patients exhibited superior overall survival (OS) across all BCLC stages (p < 0.001). Multivariate analysis identified GLIM-diagnosed malnutrition, albumin <35 g/L, tumor size >5 cm, alpha-fetoprotein (AFP) ≥400 ng/mL, and tumor number ≥3 as independent predictors of OS. The nomogram for 3-year OS achieved C-indices of 0.735 and 0.666 in the training and validation cohorts, respectively. External validation demonstrated good discrimination and calibration. The nomogram outperformed the ALBI, PNI, and BCLC staging systems in terms of AUC and DCA. CONCLUSION: GLIM-diagnosed malnutrition was an independent risk factor for OS in patients with HCC undergoing hepatectomy. The nomogram including GLIM is a good tool for predicting postoperative OS in this patient population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。